RxDoctor Payments Data

Travis Weiszhaar

Physician Assistant · Rexburg, IDNPI 1962585752

Payments from drug & device makers

$1,798in general payments, 2019–2025

Across 103 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$177
  • AbbVie$160
  • Xeris Pharmaceuticals, Inc.$136
  • Axsome Therapeutics, Inc.$96
  • Novo Nordisk$93
  • Otsuka America Pharmaceutical, Inc.$80
  • plus $1K from 32 others

What the payments were for

  • Food & beverage$1,798100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,798 in reported general payments places this provider in the 80th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$35,864
Medicare patients
217
Services billed
1,451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban51$34,459
OzempicSemaglutide21$26,262
JardianceEmpagliflozin24$24,028
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$2,802
Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro12$1,830
Levothyroxine Sodium134$1,484
Valsartan70$1,386
Carbamazepine17$981
Omeprazole99$782
Atorvastatin Calcium77$768
FenofibrateFenofibrate Nanocrystallized31$753
Metoprolol Succinate57$748
Celecoxib11$740
Gabapentin65$684
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst34$584

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$34,45951 claims
Novo NordiskOzempic$93$26,26221 claims
Boehringer IngelheimJardiance$14$24,02824 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Rexburg

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →